Obsessive–Compulsive Disorder: Treatment and Treatment Resistance

  title={Obsessive–Compulsive Disorder: Treatment and Treatment Resistance},
  author={Sean D Hood and Deirdre Alderton and David Jonathan Castle},
  journal={Australasian Psychiatry},
  pages={118 - 127}
Objective: To review the treatment options for obsessive–compulsive disorder (OCD), with particular reference to treatment resistance, and provide a guideline for clinicians managing these patients, drawing upon evidence from clinical trials and expert consensus. Conclusions: The behavioural technique of exposure and ritual prevention (EX/RP) and serotonergic medications have emerged as effective standard treatments of OCD, although full symptom remission is rare. Predictors of poor and partial… 

Figures and Tables from this paper

Antipsychotic Treatment in Obsessive Compulsive Disorder: A Literature Review

While there is little role for antipsychotic monotherapy in OCD, there is growing evidence in support of adjunctive antipsychotics in OCD refractory to serotoninreuptake inhibitors (SRIs), and studies examining augmentation with atypical agents are emerging.

Características y tratamiento del trastorno obsesivo resistente al tratamiento

The clinical profile referring obsessive patients without manifiest compulsions as a subtype of treatment-resistant obsessive-compulsive disorder (OCD), with poor response to effective treatment approaches (cognitive-behavioral therapy and pharmacotherapy) is described.

Maintenance Therapy With Electroconvulsive Therapy in a Patient With a Codiagnosis of Bipolar Disorder and Obsessive-Compulsive Disorder

A case in which depressive episode of bipolar disorder and OCD comorbidity were present and both depressive and OCD symptoms were resolved using ECT, and well-being sustained with maintenance ECT.

Electroconvulsive Therapy in Treatment-Resistant Obsessive-Compulsive Disorder Comorbid With Major Depressive Disorder: A Series of 3 Cases.

It is proposed to set up a large-scale database and multicenter collaborations to collect data on the effects of ECT in patients with CCM and other neurological disorders to facilitate research and, where possible, provide clinical guidance.

Argumentación del tratamiento psicofarmacológico y biológico en el trastorno obsesivo-compulsivo resistente y refractario.

It has been raised numerous strategies are dealth with for your management among which is the aggregate of an antipsychotic treatment with SSRIS and the use of psychosurgery.

New directions in the treatment of anxiety disorders

Patent activity for anxiolytic compounds released since 2000 within both anxiety disorderspecific and neurotransmitter-specific contexts are reviewed.

Recent developments in anxiety disorders.

The areas of current interest and possible future development of anxiolytic drugs by outlining recent patents in this field are described and grouped into neurotransmitter systems for an overview of recent developments in the neuropharmacology of anxiety disorders.

Latest guidelines for the management of the anxiety disorders – a report from The International Anxiety Disorders Society Conference, Melbourne 2014

  • S. Hood
  • Psychology, Medicine
    Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists
  • 2015
The proceedings of the International Anxiety Disorders Society Conference, held in Melbourne in November 2014, are to be published as articles in this issue of Australasian Psychiatry.


It’s time to get used to the idea that there is no such thing as a good time to be afraid of heights.


La presente investigacion tuvo como objetivo comparar dos grupos de pacientes con Trastorno Obsesivo Compulsivo (TOC), uno compuesto por pacientes con obsesiones endogenas (n=26) y otro integrado por



Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review.

  • J. Abramowitz
  • Psychology
    Journal of consulting and clinical psychology
  • 1997
Quantitative review of the controlled treatment outcome literature for obsessive-compulsive disorder (OCD) showed that exposure with response prevention was highly effective in reducing OCD symptoms.

Cognitive Therapy of Obsessive – compulsive Disorder: Treating Treatment Failures

It is argued that cognitive–behavioural interventions such as the one described here may be useful as an adjunct to more traditional behavioural treatments for obsessional disorders as well as in the treatment of patients with overvalued ideation.

Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.

Clinical patients achieved substantial and clinically meaningful reductions in their OCD and depressive symptoms following EX/RP, which were comparable with those reported in the RCTs.

Organicity in Obsessive-Compulsive Disorder

The OCD clinical profile that is correlated to organicity is described and reasons for lack of response in organic OCD patients, based on cerebral anatomical changes, are discussed.

Predictors of drug treatment response in obsessive-compulsive disorder.

There are distinct types of OCD with respect to drug treatment response, which provide indirect evidence of treatment specificity by identifying characteristics responsive to different modalities, which may be of value in the selection of patients for alternative treatments.

Obsessive-Compulsive Disorder

Optimal results in the management of OCD are often realised through a combination of ERP and pharmacological therapy, although the availability of behavioural therapy is limited.

What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder?

Clinical improvement was associated with never having been treated previously, being employed during treatment, having a fear of contamination, having overt ritualistic behaviour, the absence of depression and living with one's family.

On the Pharmacotherapy of Obsessive—Compulsive Disorder: Is a Consensus Possible?

The available research evidence suggests that clomipramine possesses greater antiobsessional efficacy than do the SSRIs, and may be used as first-line treatments for OCD when properly used in small initial doses with gradual increases.

Efficacy of Drug Treatment in Obsessive–Compulsive Disorder: a Meta-Analytic Review

Antidepressant drugs are effective in the short-term treatment of patients suffering from OCD; although the increase in improvement rate over placebo was greater for clomipramine than for SSRIs, direct comparison between these drugs showed that they had similar therapeutic efficacy on obsessive–compulsive symptoms.